MedTrace Logo

Remdesivir Efficacy in Coronavirus Disease

NCT04345419 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2021-08-02

No results posted yet for this study

Summary

COVID 19 treatment using Remedesvir.

Conditions

Interventions

DRUG

Remdesivir

Remdesivir as antiviral drug

OTHER

Standard of care treatment

Standard of care treatment

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Sherief Abd-Elsalam, ass. prof. · Tanta University Faculty of medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-16
Primary Completion
2020-12-01
Completion
2020-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04345419 on ClinicalTrials.gov